Issue 193

16.04.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

Reimbursed sales of medical cannabis in Germany 2020REIMBURSED SALES OF MEDICAL CANNABIS GREW BY 34% IN 2020

The German National Association of Statutory Health Insurance Funds (GKV), whose members insure 90% of the population, has released the data on reimbursed medical cannabis usage covering the entirety of 2020, revealing that total reimbursements amounted to €165 million in the year.

The GKV has also released data showing that the market for medical cannabis in Germany continued to grow in 2020, increasing by 34% compared to 2019 excluding the newly added product Epidiolex.

READ NOW

 


 

CURALEAF CEO BORIS JORDAN AMONG SPEAKERS AT PROHIBITION PARTNERS LIVE

READ MORE »

 

NEW MEXICO BECOMES LATEST US STATE TO LEGALISE ADULT-USE CANNABIS

READ MORE »

Europe

FEATURE

LAUNCH OF CANNABIS INDUSTRY COUNCIL IS A SIGNIFICANT AND ‘POSITIVE MILESTONE’ FOR THE UK

A NEW UK Cannabis Industry Council is being created with the aim of providing a platform for the industry to speak with a unified voice. It is being driven initially by industry expert Professor Mike Barnes – Chairman of the Medical Cannabis Clinicians Society – and aims to unite 100 companies in the initial stage.

Speaking to BusinessCann, Prohibition Partners Co-Founder Stephen Murphy said: ‘The UK is emerging as a European leader and the Cannabis Industry Council will have a significant role to play if we are going to achieve our potential.’

READ NOW

USA

CANADA

LATAM & CARIBBEAN

APAC

AFRICA & MIDDLE EAST

Read the stories that shape the cannabis industry